Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 2
2007 5
2008 1
2009 5
2010 14
2011 11
2012 12
2013 8
2014 8
2015 7
2016 6
2017 3
2018 6
2019 10
2020 10
2021 15
2022 11
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Patient-Derived Organoids for Precision Cancer Immunotherapy.
Grönholm M, Feodoroff M, Antignani G, Martins B, Hamdan F, Cerullo V. Grönholm M, et al. Among authors: cerullo v. Cancer Res. 2021 Jun 15;81(12):3149-3155. doi: 10.1158/0008-5472.CAN-20-4026. Epub 2021 Mar 9. Cancer Res. 2021. PMID: 33687948 Review.
Personalizing Oncolytic Virotherapy.
Hamdan F, Fusciello M, Cerullo V. Hamdan F, et al. Among authors: cerullo v. Hum Gene Ther. 2023 Sep;34(17-18):870-877. doi: 10.1089/hum.2023.122. Hum Gene Ther. 2023. PMID: 37698876 Review.
Pathogens: Our Allies against Cancer?
Buonaguro L, Cerullo V. Buonaguro L, et al. Among authors: cerullo v. Mol Ther. 2021 Jan 6;29(1):10-12. doi: 10.1016/j.ymthe.2020.12.005. Epub 2020 Dec 5. Mol Ther. 2021. PMID: 33308440 Free PMC article. Review. No abstract available.
Oncolytic Adenoviruses for Cancer Therapy.
Tripodi L, Vitale M, Cerullo V, Pastore L. Tripodi L, et al. Among authors: cerullo v. Int J Mol Sci. 2021 Mar 3;22(5):2517. doi: 10.3390/ijms22052517. Int J Mol Sci. 2021. PMID: 33802281 Free PMC article. Review.
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.
Chiaro J, Antignani G, Feola S, Feodoroff M, Martins B, Cojoc H, Russo S, Fusciello M, Hamdan F, Ferrari V, Ciampi D, Ilonen I, Räsänen J, Mäyränpää M, Partanen J, Koskela S, Honkanen J, Halonen J, Kuryk L, Rescigno M, Grönholm M, Branca RM, Lehtiö J, Cerullo V. Chiaro J, et al. Among authors: cerullo v. Nat Commun. 2023 Nov 3;14(1):7056. doi: 10.1038/s41467-023-42668-7. Nat Commun. 2023. PMID: 37923723 Free PMC article.
Translational Aspects of Epithelioid Sarcoma: Current Consensus.
Grünewald TGP, Postel-Vinay S, Nakayama RT, Berlow NE, Bolzicco A, Cerullo V, Dermawan JK, Frezza AM, Italiano A, Jin JX, Le Loarer F, Martin-Broto J, Pecora A, Perez-Martinez A, Tam YB, Tirode F, Trama A, Pasquali S, Vescia M, Wortmann L, Wortmann M, Yoshida A, Webb K, Huang PH, Keller C, Antonescu CR. Grünewald TGP, et al. Among authors: cerullo v. Clin Cancer Res. 2024 Mar 15;30(6):1079-1092. doi: 10.1158/1078-0432.CCR-23-2174. Clin Cancer Res. 2024. PMID: 37916971 Free PMC article. Review.
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.
Manfredi F, Stasi L, Buonanno S, Marzuttini F, Noviello M, Mastaglio S, Abbati D, Potenza A, Balestrieri C, Cianciotti BC, Tassi E, Feola S, Toffalori C, Punta M, Magnani Z, Camisa B, Tiziano E, Lupo-Stanghellini MT, Branca RM, Lehtiö J, Sikanen TM, Haapala MJ, Cerullo V, Casucci M, Vago L, Ciceri F, Bonini C, Ruggiero E. Manfredi F, et al. Among authors: cerullo v. Sci Adv. 2023 Dec;9(48):eadg8014. doi: 10.1126/sciadv.adg8014. Epub 2023 Dec 1. Sci Adv. 2023. PMID: 38039364 Free PMC article.
Cancer immunotherapies: A hope for the uncurable?
Hamdan F, Cerullo V. Hamdan F, et al. Among authors: cerullo v. Front Mol Med. 2023 Feb 17;3:1140977. doi: 10.3389/fmmed.2023.1140977. eCollection 2023. Front Mol Med. 2023. PMID: 39086690 Free PMC article. Review.
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma.
Tripodi L, Feola S, Granata I, Whalley T, Passariello M, Capasso C, Coluccino L, Vitale M, Scalia G, Gentile L, De Lorenzo C, Guarracino MR, Castaldo G, D'Argenio V, Szomolay B, Cerullo V, Pastore L. Tripodi L, et al. Among authors: cerullo v. iScience. 2023 Aug 19;26(10):107668. doi: 10.1016/j.isci.2023.107668. eCollection 2023 Oct 20. iScience. 2023. PMID: 37720092 Free PMC article.
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy.
Russo S, Feola S, Feodoroff M, Chiaro J, Antignani G, Fusciello M, D'Alessio F, Hamdan F, Pellinen T, Mölsä R, Tripodi L, Pastore L, Grönholm M, Cerullo V. Russo S, et al. Among authors: cerullo v. Mol Ther Oncol. 2024 Jan 26;32(1):200766. doi: 10.1016/j.omton.2024.200766. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596301 Free PMC article.
135 results